Inflammation Pathways in Breast Cancer
Inflammation Pathways in Breast Cancer
批准号:
7212734
负责人:
MARGARET M MADELEINE
金额:
$38.27万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-26 至 2011-07-31
关键词:
AccountingAffectAgeAge at MenarcheAlcohol consumptionAlcoholsAnti-Inflammatory AgentsAnti-inflammatoryArthritisBlood specimenBody WeightBreast Cancer Risk FactorCase-Control StudiesCell ProliferationChronicClinicalColorectal CancerComplexConditionCytokine GeneDataDrug PrescriptionsDrug usageEnvironmentEnvironmental Risk FactorEstrogensFirst BirthsGenesGeneticGenetic PolymorphismGenetic VariationHeart DiseasesHormone replacement therapyHormonesIL2 geneIL6 geneIL8 geneImmune responseInflammationInflammatory ResponseInterleukin-1Interleukin-10Interleukin-12Interleukin-2InterviewLeadLeptinLigandsLinkLiteratureMediatingMenopauseMethodsMorbidity - disease rateNewly DiagnosedObesityOverweightPathway interactionsPersonsPhysical activityPopulationPostmenopausePreventionPrevention strategyReproductive HistoryResearch PersonnelRiskRisk FactorsScreening procedureSmokingTNF geneTechniquesTimeTranslatingVariantWomanadiponectinage groupanakinrabasecancer riskcytokinecytotoxicdaydisorder riskinsightmalignant breast neoplasmolder womenprogramsreceptorresponse
中文摘要
描述(由申请人提供):65-79岁女性的乳腺癌占所有新诊断乳腺癌的50%以上,但已知的遗传和环境风险因素占一小部分风险。大多数已知的、适度升高的老年妇女乳腺癌危险因素,其病因学重要性可追溯到累积雌激素暴露。老年妇女中其他适度升高的危险因素,如肥胖、饮酒和缺乏体育活动等,可能通过刺激慢性激活的促炎免疫反应与乳腺癌有关,这种免疫反应具有直接的细胞毒性或基因毒性
英文摘要
DESCRIPTION (provided by applicant): Breast cancers in women 65-79 years old comprise over 50% of all newly diagnosed breast cancers, and yet known genetic and environmental risk factors account for a small percentage of risk. The majority of the recognized, modestly elevated risk factors for breast cancer in older women trace their etiologic importance to cumulative estrogen exposure. Other modestly elevated risk factors in older women, such as those associated with obesity, alcohol use, and physical inactivity, may be linked to breast cancer through stimulation of a chronically activated proinflammatory immune response that has direct cytotoxic or genotoxic
effects. We will build on a completed study of breast cancer in older women (ages 65-79) to assess the possibility that single or multiple polymorphisms in the cytokine-driven inflammation pathways lead to an unbalanced immune response that favors uncontrolled cell proliferation and, over time, breast cancer. We hypothesize that 1) Variation in cytokine genes that favor a proinflammatory response are associated with an increased risk of breast cancer in older women, whereas those that favor an anti-inflammatory response are associated with a decreased risk. We will evaluate whether polymorphisms in proinflammatory (IL1, IL6, IL8, IL12, TNF, and leptin) and anti- flammatory (IL1RN, IL2, IL10, adiponectin) genes and their receptors alter the risk of breast cancer; 2) The impact of specific gene-gene and gene-environment combinations alter the
risk of breast cancer in older women (e.g., ligand-receptor pairs, IL6 and leptin, TNF and alcohol). As cytokines constitute the basic wiring that mediates the inflammatory response and since older women have different cytokine profiles compared to younger women that indicate a low-grade systemic inflammatory response, we propose that variation in cytokine genes are key players in translating exposures common in older women to risk factors for breast cancer and may provide insight into strategies for prevention in this age group, the women who are most at risk for breast cancer. Lay Summary: We plan to study the risk of postmenopausal breast cancer associated with cytokine genes that underlie a low-grade, chronic inflammatory response. Cytokine genes are expressed at different levels in older compared to younger women; therefore, we will also evaluate their contribution to breast cancer risk by levels of common exposures such as obesity and HRT use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Trials Program
-
批准号:10020373
-
项目类别:
-
资助金额:$53.27万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Clinical Trials Program
-
批准号:10224783
-
项目类别:
-
资助金额:$19.96万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Administrative and Coordinating Core
-
批准号:10224782
-
项目类别:
-
资助金额:$12.92万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Clinical Trials Program
-
批准号:10470116
-
项目类别:
-
资助金额:$5.64万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Administrative and Coordinating Core
-
批准号:10689735
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Administrative and Coordinating Core
-
批准号:10020372
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Clinical Trials Program
-
批准号:10601389
-
项目类别:
-
资助金额:$25.72万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Administrative and Coordinating Core
-
批准号:10470114
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Clinical Trials Program
-
批准号:10689736
-
项目类别:
-
资助金额:$40.16万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Administrative and Coordinating Core
-
批准号:10601388
-
项目类别:
-
资助金额:$20.96万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
-
批准号:9220396
-
项目类别:
-
资助金额:$76.78万
-
财政年份:2017
-
负责人:MARGARET M MADELEINE
-
依托单位:
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
-
批准号:10098635
-
项目类别:
-
资助金额:$13.42万
-
财政年份:2017
-
负责人:MARGARET M MADELEINE
-
依托单位:
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
-
批准号:10230257
-
项目类别:
-
资助金额:$25.14万
-
财政年份:2017
-
负责人:MARGARET M MADELEINE
-
依托单位:
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
-
批准号:10113554
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2017
-
负责人:MARGARET M MADELEINE
-
依托单位:
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
-
批准号:10359814
-
项目类别:
-
资助金额:$78.07万
-
财政年份:2017
-
负责人:MARGARET M MADELEINE
-
依托单位:
Post GWA Analysis of Inflammation Pathways in Barrett's and Esophageal Cancer
-
批准号:8702512
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2014
-
负责人:MARGARET M MADELEINE
-
依托单位:
BIOSTATISTICS AND DATA MANAGEMENT
-
批准号:8307531
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2011
-
负责人:MARGARET M MADELEINE
-
依托单位:
EPIDEMIOLOGY OF HPV-RELATED SCSC IN TRANSPLANT PATIENTS
-
批准号:8307527
-
项目类别:
-
资助金额:$43.17万
-
财政年份:2011
-
负责人:MARGARET M MADELEINE
-
依托单位:
BIOSTATISTICS AND DATA MANAGEMENT
-
批准号:7305823
-
项目类别:
-
资助金额:$29.33万
-
财政年份:2007
-
负责人:MARGARET M MADELEINE
-
依托单位:
Inflammation Pathways in Breast Cancer
-
批准号:7663814
-
项目类别:
-
资助金额:$56.79万
-
财政年份:2007
-
负责人:MARGARET M MADELEINE
-
依托单位:
海外基金